dehydroepiandrosterone sulfate has been researched along with HIV Lipodystrophy Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, O; Hansen, BR; Haugaard, SB; Iversen, J; Madsbad, S; Nielsen, JO; Paulsen, SK; Pedersen, SB; Rathje, GS; Richelsen, B; Svenstrup, B | 1 |
1 other study(ies) available for dehydroepiandrosterone sulfate and HIV Lipodystrophy Syndrome
| Article | Year |
|---|---|
Circulating sex hormones and gene expression of subcutaneous adipose tissue oestrogen and alpha-adrenergic receptors in HIV-lipodystrophy: implications for fat distribution.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aromatase; Body Composition; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Receptor alpha; Gene Expression; Glycerol; Gonadal Steroid Hormones; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Linear Models; Lipolysis; Male; Receptors, Adrenergic, alpha-2; Sex Hormone-Binding Globulin; Subcutaneous Fat; Testosterone | 2007 |